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Summary 
Objectives:  To determine the sensitivity and specificity of a novel ELISA for the 
serodiagnosis of surgical site infection (SSI) due to staphylococci following median 
sternotomy. 
 
Methods:  Twelve patients with a superficial sternal SSI and 19 with a deep sternal SSI 
due to S. aureus were compared with 37 control patients who also underwent median 
sternotomy for cardiac surgery but exhibited no microbiological or clinical symptoms of 
infection.  A further 5 patients with sternal SSI due to coagulase-negative (CoNS) 
staphylococci were studied.  An ELISA incorporating a recently recognised exocellular 
short chain form of lipoteichoic acid (lipid S) recovered from CoNS, was used to 
determine serum levels of anti-lipid S IgG in all patient groups. 
 
Results:  Serum anti-lipid S IgG titres of patients with sternal SSI due to S. aureus were 
significantly higher than the control patients (P 0.0001).  In addition, patients with deep 
sternal SSI had significantly higher serum anti-lipid S IgG titres than patients with 
superficial sternal SSI (P=0.03).  Serum anti-lipid S IgG titres of patients with sternal 
SSI due to CoNS were significantly higher than the control patients (P=0.001). 
 
Conclusion:  The lipid S ELISA may facilitate the diagnosis of sternal SSI due to S. 
aureus and could also be of value with infection due to CoNS.   
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Introduction 
 
Surgical site infection (SSI) following median sternotomy is an uncommon but 
potentially fatal complication of cardiac surgery.  The reported incidence of sternal SSI 
varies widely and ranges between 0.9% and 20%.
1
  Furthermore, the attributable costs of 
sternal SSI following median sternotomy are particularly high.  Indeed, patients with a 
deep chest wall SSI following coronary artery bypass grafting (CABG) have a 20 day 
increase in hospitalisation, attributable costs of 20,000 US dollars and a mortality rate of 
22%.2-3 
 
Early and accurate diagnosis of sternal SSIs is crucial for successful treatment.  Grossi 
and colleagues (1985) suggested that 80% of sternal SSI may be eradicated by simple 
surgical debridement or closed antibiotic irrigation if the diagnosis is established within 
20 days. However if diagnosis is delayed, surgical debridement followed by muscle flap 
reconstruction may be required.
4
  Sternal SSI is often diagnosed by the presence of 
symptoms of local inflammation including; purulent exudate, erythema, tenderness, 
pyrexia, elevated levels of serum inflammatory markers 
5
 and by an abnormal 
computerised tomography scan.
6
  Diagnosis of sternal wound infections is difficult in 
the early postoperative period due to the general inflammatory response that follows 
extracorporeal circulation.
7
  Use of inflammatory markers to aid diagnosis during this 
period is therefore of limited value.
8,9  
Most imaging techniques which are used for the 
diagnosis of sternal SSI are based on the visualisation of anatomical structures and are 
limited in their diagnostic value as infection is indistinguishable from surgical artefacts 
and the presence of oedema, haematoma or haemorrhage which are often present in 
normal patients recovering from cardiac surgery.
10   
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The microorganisms most commonly recovered from sternal SSI are S. aureus and 
coagulase-negative staphylococci (CoNS) which account for 32% and 23% of sternal 
SSI respectively.
11
 Microbiological culture of clinical material from the sternal SSI is 
often required to confirm the clinical diagnosis. However this may be complicated by 
the use of prophylactic antibiotics used for cardiac surgery.
  
In addition, interpretation of 
sternal cultures yielding CoNS, a major cause of sternal SSI, is complicated as the 
isolated microorganisms may represent skin contamination.   
 
Serological diagnosis of sternal SSI due to S. aureus relies mainly on the widely used 
anti-staphylolysin test (ASTA).  However, the assay lacks sensitivity and is only 
designed for the diagnosis of infection due to S. aureus and not CoNS.
12
 Enzyme-linked 
immunosorbent assay (ELISA) is a frequently utilised, inexpensive, simple serological 
technique for the serodiagnosis of several types of infections.  We have recently 
developed a rapid, indirect ELISA incorporating lipid S, a novel exocellular short chain 
form of lipoteichoic acid probably produced by most strains of staphylococci, for the 
diagnosis of deep-seated staphylococcal infection.
13-15
  The ELISA has previously been 
used to facilitate the diagnosis of central venous catheter related bloodstream 
infection,
13,14 
endocarditis,
16
 prosthetic joint infection
17
 and pyogenic spondylodiscitis.
18
  
 
In this current study, serum antibody levels of anti-lipid S IgG were determined in 
cardiac surgery patients with clinical and microbiological evidence of S. aureus and 
CoNS sternal SSI following median sternotomy and compared to patients with no 
infectious complications following the same type of surgical procedure. 
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Materials and Methods 
Patients 
Thirty-one patients at the Cardiac Surgery Critical Care Unit, University Hospital, 
Birmingham, UK who were diagnosed as having a S. aureus sternal SSI following 
elective cardiac surgery were entered into the study.  A further 5 patients with sternal 
SSI due to coagulase-negative (CoNS) staphylococci were included.  Patients with other 
foci of infection were excluded from the study.  CDC guidelines were utilised to 
determine sternal SSI.
19
 These patients were compared with 37 randomly selected 
cardiac surgery patients with no evidence of infectious complications following surgery.  
In both patient groups, only patients with no evidence of infection in the 6 months prior 
to surgery were recruited.  Clotted blood samples were obtained five days post-cardiac 
surgery from control patients (immediately prior to discharge in patients with no post-
operative complications) and from infected patients at the time sternal SSI was 
diagnosed microbiologically.  Serum IgG titres to lipid S was subsequently determined 
on these samples.  Ethical committee approval was obtained prior to undertaking the 
study.  
 
Preparation of lipid S-coated plates 
The lipid S-coated plates were prepared as outlined previously.
13-15  
In brief, the lipid S 
antigen was prepared from seven pooled strains of CoNS, all isolated from patients with 
proven staphylococcal infection.  Antigen was recovered by gel permeation 
chromatography (Superose 12) from broth culture.  Purified antigen, in carbonate buffer, 
was used to coat the microtitre plate. 
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Lipid S ELISA 
The lipid S ELISA was performed as outlined by Worthington and colleagues.
13  
Patients’ sera were diluted 1 in 6400 in TBS/Tween buffer and 100 l was added to each 
well of the plate.  After incubation for two hours at 37 C, excess serum was removed 
and the plates were washed with TBS/Tween buffer.  Antihuman IgG conjugate (Sigma, 
Poole, Dorset, UK); diluted 1 in 5000 in TBS/Tween buffer was then added to each well 
and incubated for one hour at 37 C for the detection of  bound IgG.  After removal of 
the conjugate, 100 l of chromogenic substrate was added to each well.  Following 25 
minutes of incubation at 37 C, the reaction was stopped by the addition of 100 l 
sulphuric acid (1M) after which, the optical density was read at 450nm.  All sera, 
including positive and negative controls were tested in duplicate.   
 
Statistics 
Titres were compared using the Mann-Whitney U and Spearman Rank tests. 
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Results 
Patients 
Sevently-three patients were recruited into the study and were classified as follows; 14 
with superficial sternal SSI (12 due to S. aureus and 2 due to CoNS), 22 patients with 
deep sternal SSI (19 due to S. aureus and 3 due to CoNS) and 37 control patients with 
no microbiological or clinical evidence of infection.  Patients first presented with 
superficial sternal SSI a mean of 15 days post-operatively (range 4-30) whereas patients 
with deep sternal SSI were diagnosed on average, 29 days post-operatively (range 2-
270) Patient demographics are given in table I.   
 
Serology 
Anti-lipid S IgG titres in the patient groups are shown in table II.  A scatter graph 
demonstrating the range of serum IgG titres to lipid S is given in figure 1.  The serum 
IgG titres of patients with S. aureus sternal SSI were significantly higher than the control 
group (P 0.0001).  In addition, patients with deep sternal SSI had significantly higher 
serum anti-lipid S IgG titres than patients with superficial sternal SSI (P=0.02).  All five 
patients with sternal SSI due to CoNS had positive anti-lipid S IgG titres.  Indeed, serum 
anti-lipid S IgG titres of patients with sternal SSI due to CoNS were significantly higher 
than the control patients (P=0.001).  However, due to the small number of patients in 
this group, further evaluation of patients with SSI due to CoNS is required to confirm 
this trend.  There was no correlation between the time post-surgically that the sternal 
SSI developed and the antibody titres in either the superficial or deep sternal SSI groups 
(P=0.3 and P=0.4 respectively).     
 
The diagnostic parameters of the Lipid S ELISA are shown in table III.  
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Discussion 
Sternal SSI is a serious condition with a significant associated morbidity and mortality.  
It is imperative that the diagnosis is established early so that treatment can commence.  
Several methods have been evaluated to diagnose sternal wound SSIs including; 
standard microbiological culture, sternal puncture,
21
 infrared thermography of 
peristernal skin,
22
 computed tomography, 
6, 23
 plain radiography 
23
 and radionucleotide 
imaging techniques using; Indium-111 labelled leukocytes,
6
 Technetium-99m- labelled 
leukocytes 
7 
and monoclonal antigranulocyte antibodies.
7
  However, all these current 
diagnostic techniques are often time consuming, expensive and lack sensitivity. The 
anti-staphylolysin test (ASTA) which is widely used in routine microbiology 
laboratories may aid in the diagnosis of SSI due to S. aureus, however the test has a poor 
sensitivity.  Indeed, a study which evaluated the ASTA in patients with osteomyelitis 
due to S. aureus demonstrated on assay a sensitivity of 47% and specificity of 96%.
12
  
 
The results of this current study highlight the potential of the lipid S ELISA as a rapid 
serological test to facilitate the diagnosis of sternal SSI due to both S. aureus and 
possibly CoNS.  The test overall for S. aureus had a sensitivity of 68% and specificity of 
97%, which compares well to previous studies which used this ELISA to diagnose 
central venous catheter-related infection,
13
 endocarditis 
16
 and prosthetic joint 
infection.
17
  The sensitivity of this test for S. aureus was higher in patients with deep 
sternal SSI (79%) compared to those with superficial sternal SSI (50%).  This may be 
due to the chronic nature of deep SSI.  Indeed, the sensitivity of the lipid S ELISA has 
been demonstrated to be higher in chronic infections such as endocarditis.
16
 
 
Difficulties in determining whether or not CoNS are associated with sternal SSI or are 
sample contaminants remains a diagnostic challenge.  The results in this study suggest 
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that the lipid S ELISA may aid in the diagnosis of true infection due to CoNS and may 
also provide a useful adjunct when interpreting cultures from patients with sternal SSI.   
 
Approximately 30% of patients in this study with a clinical diagnosis of sternal SSI had 
no anti-lipid S IgG detected.  There are several possibilities reasons for this observation.  
The time of onset of infection to collection of serum samples may not have been optimal 
to detect sufficient anti-lipid S IgG titres or the strain of S. aureus associated with the 
infection may have produced little or no exocellular lipid S antigen. These possibilities, 
in particular whether all staphylococcal strains produce lipid S and how anti-lipid S 
titres vary with time postoperatively in infected and non-infected individuals require 
further investigation.   
 
In conclusion we present a sensitive and specific indirect ELISA for the rapid 
serodiagnosis of sternal SSI due to S. aureus which may aid in optimising patient 
management before culture results become available.  The assay results from the five 
patients infected with CoNS also showed promising results. Further assessment of the 
lipid S ELISA for diagnosing these infections in particular those caused by CoNS is 
required in the clinical setting. 
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Table I - Patient Demographics and Surgical procedures 
 
 
 Control group (n=37) Superficial sternal SSI due to 
S. aureus (CoNS) 
Deep sternal SSI due to  
S. aureus (CoNS) 
Mean age (years) 65 59 (67) 69 (65) 
Age range (years) 43-82 48-74 (64-69) 51-80 (59-75) 
Male 32 6 (2) 15 (3) 
Female 5 6 (0) 4 (0) 
Procedure: CABG 29 9 (2) 14 (3) 
Valvular surgery  8 2 (0) 3 (0) 
CABG and valvular surgery 0 1 (0) 1 (0) 
Aortic surgery 0 0 (0) 1 (0) 
 
CABG (Coronary Artery Bypass Graft) 
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Table II - Serum IgG titres to lipid S in patients with superficial or deep sternal SSI and non-infected controls.  
 
Patient group  Superficial 
incisional SSI 
Deep  
incisional SSI 
Total in patient 
group 
S.aureus sternal SSI Total  12 19 31 
 Number with positive IgG titres (%) 6 (50%) 15 (79%) 21 (68%) 
 Mean anti-Lipid S IgG titre 7401 21068.3 15778 
 Titre range ND - 34479 ND - 51874 ND - 51874 
CoNS sternal SSI Total  2 3 5 
 Number with positive IgG titres (%) 2 (100%) 3 (100%) 5 (100%) 
 Mean anti-Lipid S IgG titre 2999 3163 3097 
 Titre range 2243 - 3755 314 - 7372 314 - 7372 
Non-infected patients Total - - 37 
 Number with positive IgG titres (%) - - 1 (3%) 
 Mean anti-Lipid S IgG titre - - 251 
 Titre range - - ND - 9293 
 
ND = non-detectable 
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Table III - The diagnostic parameters of the lipid S ELISA for sternal SSI due to S. aureus. 
 
 Superficial sternal SSI Deep sternal SSI Total sternal SSI 
Sensitivity 50% 79% 68% 
Specificity 97% 97% 97% 
Positive predictive value 86% 94% 95% 
Negative predictive value 86% 90% 78% 
Accuracy 86% 89% 84% 
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Figure 1 – Scattergram demonstrating the range of serum anti-lipid S IgG titres in patients with staphylococcal 
sternal SSI and controls. 
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